Infectious Agents and Cancer is affiliated with the African Organisation for Research & Training In Cancer (AORTIC)
Articles
Page 14 of 21
-
Citation: Infectious Agents and Cancer 2012 7(Suppl 1):P49
-
[18F]-fluoro-D-deoxyglucose positron emission tomography findings in Kaposi sarcoma herpes virus associated multicentric Castleman disease: correlation with clinical, inflammatory, and virologic parameters
Citation: Infectious Agents and Cancer 2012 7(Suppl 1):P48 -
Effect of immunodeficiency and tumor marker expression on HIV-related diffuse large B-cell lymphoma prognosis
Citation: Infectious Agents and Cancer 2012 7(Suppl 1):P47 -
Pathogen discovery in AIDS-related lymphoma by high-throughput sequencing
Citation: Infectious Agents and Cancer 2012 7(Suppl 1):P45 -
The prevalence of HIV-1 DNA in AIDS-related lymphoma and Kaposi Sarcoma throughout the AIDS epidemic
Citation: Infectious Agents and Cancer 2012 7(Suppl 1):P43 -
KSHV induces rapid release of angiopoietin-2 from endothelial cells to promote angiogenesis and inflammation
Citation: Infectious Agents and Cancer 2012 7(Suppl 1):P41 -
KSHV encoded miRNA single nucleotide polymorphisms identified in clinical samples can affect miRNA processing and level of expression
Citation: Infectious Agents and Cancer 2012 7(Suppl 1):P40 -
Kaposi sarcoma herpesvirus (KSHV)-associated lymphomas are associated with markedly elevated serum IL-10, elevated IL-6, IL-17 and circulating KSHV
Citation: Infectious Agents and Cancer 2012 7(Suppl 1):P39 -
Induction of KSHV latency-associated nuclear antigen (LANA) by hypoxia and hypoxia-inducible factors (HIF)
Citation: Infectious Agents and Cancer 2012 7(Suppl 1):P37 -
HPV+ cancer cell lactate production attenuates immune response during treatment: lactate production inhibition leads to improved long-term cures
Citation: Infectious Agents and Cancer 2012 7(Suppl 1):P35 -
Global expression analysis of EBV-infected B cells early and late after infection reveals a dynamic interplay between growth and survival signals
Citation: Infectious Agents and Cancer 2012 7(Suppl 1):P34 -
Epstein-Barr virus lytic gene expression is tightly linked to ER stress but not cytotoxicity with bortezomib or nelfinavir
Citation: Infectious Agents and Cancer 2012 7(Suppl 1):P32 -
Development of multiplex serological assays to detect oncoviral infections
Citation: Infectious Agents and Cancer 2012 7(Suppl 1):P30 -
A regulatory circuit between Kaposi sarcoma-associated herpesvirus and host innate immune system
Citation: Infectious Agents and Cancer 2012 7(Suppl 1):P28 -
Risk factors for squamous cell skin cancer in HIV
Citation: Infectious Agents and Cancer 2012 7(Suppl 1):O26 -
Hodgkin’s lymphoma characteristics in HIV-infected and uninfected patients at an urban hospital in the late combined antiretroviral era
Citation: Infectious Agents and Cancer 2012 7(Suppl 1):P26 -
Incidence and risk factors for lung cancer among women in the women's interagency HIV study (WIHS) and men in the multicenter AIDS cohort study (MACS)
Citation: Infectious Agents and Cancer 2012 7(Suppl 1):O24 -
The AIDS malignancy clinical trials consortium (AMC) patient navigator (PN) initiative
Citation: Infectious Agents and Cancer 2012 7(Suppl 1):P24 -
Decline in EBV-Specific IFN T cell responses in Kenyan infants from a malaria holoendemic region of Kenya
Citation: Infectious Agents and Cancer 2012 7(Suppl 1):O22 -
R-CHOP versus CHOP in HIV-associated lymphoma: a meta-analysis of prospective studies
Citation: Infectious Agents and Cancer 2012 7(Suppl 1):P22 -
Incidence of Kaposi Sarcoma in HIV-infected patients – a prospective multi-cohort study from Southern Africa
Citation: Infectious Agents and Cancer 2012 7(Suppl 1):O20 -
Multicentric Castleman’s disease in HIV/AIDS patients at an urban HIV clinic in Atlanta, Georgia, in the combined antiretroviral therapy era
Citation: Infectious Agents and Cancer 2012 7(Suppl 1):P20 -
Prospective evaluation of the impact of potent antiretroviral therapy on the incidence of Kaposi’s Sarcoma in East Africa: findings from the International Epidemiologic Databases to Evaluate AIDS (IeDEA) Consortium
Citation: Infectious Agents and Cancer 2012 7(Suppl 1):O19 -
Pap testing among newly diagnosed women living with HIV/AIDS (WLWHA) in South Carolina (SC): routine screening and abnormal follow-up behaviors of HIV-positive female SC medicaid recipients 18-64 years between 2005-2009
Citation: Infectious Agents and Cancer 2012 7(Suppl 1):P18 -
Risk factors for death and temporal trends in overall survival in patients with AIDS-associated primary central nervous system lymphoma (AIDS-PCNSL)
Citation: Infectious Agents and Cancer 2012 7(Suppl 1):O18 -
Serum levels of several molecules that are associated with B cell activation and inflammation are elevated in AIDS-associated non-Hodgkin’s lymphoma (AIDS-NHL) and predict response to treatment
Citation: Infectious Agents and Cancer 2012 7(Suppl 1):O16 -
Knowledge attitude and practice of malignancies among PLWHIV in Nigeria
Citation: Infectious Agents and Cancer 2012 7(Suppl 1):P16 -
A phase 1/PK study of Sunitinib with highly active antiretroviral therapy (HAART) in HIV+ patients with solid tumors: AIDS malignancy consortium study 061
Citation: Infectious Agents and Cancer 2012 7(Suppl 1):O15 -
Modified dose intensive R- CODOX-M/IVAC for HIV-associated burkitt (BL) (AMC 048) shows efficacy and tolerability, and predictive potential of IRF4/MUM1 expression
Citation: Infectious Agents and Cancer 2012 7(Suppl 1):O14 -
Digital cervicography and cold coagulation for cervical cancer screening in Nigeria
Citation: Infectious Agents and Cancer 2012 7(Suppl 1):P14 -
Making the case for better integration of cervical cancer screening and treatment for HIV-infected women attending care and treatment clinics in Dar es Salaam, Tanzania
Citation: Infectious Agents and Cancer 2012 7(Suppl 1):P13 -
Human papillomavirus prevalence in invasive cervical carcinoma by HIV Status
Citation: Infectious Agents and Cancer 2012 7(Suppl 1):O12 -
HIV-associated non-Hodgkin's lymphoma-experience from a tertiary referral cancer center
Citation: Infectious Agents and Cancer 2012 7(Suppl 1):P12 -
HIV/AIDS-related non-Hodgkin's lymphomas and confounders: preliminary report of the Sub-Saharan Africa Lymphoma Consortium (SSALC)
Citation: Infectious Agents and Cancer 2012 7(Suppl 1):P11 -
Detection of helicobacter pylori in benign laryngeal lesions by polymerase chain reaction: a cross sectional study
Although Helicobacter Pylori (HP) was detected in some cases of chronic laryngitis, the results were not confirmed by polymerase chain reaction (PCR). By this time, it has not been found in laryngeal lesions b...
Citation: Infectious Agents and Cancer 2012 7:10 -
The impact of the HIV epidemic on U.S. anal cancer rates, 1980-2007
Citation: Infectious Agents and Cancer 2012 7(Suppl 1):O10 -
Gender differences in HIV-infected and HIV-uninfected patients with lung cancer
Citation: Infectious Agents and Cancer 2012 7(Suppl 1):P10 -
Factors associated with cancer pathogenesis among patients attending oncology clinic at Kamuzu Central Hospital in Malawi
Citation: Infectious Agents and Cancer 2012 7(Suppl 1):P9 -
Determinants of mTOR inhibitor therapy in AIDS-associated malignancies
Citation: Infectious Agents and Cancer 2012 7(Suppl 1):O9 -
Evaluation of the AIDS clinical trials group staging criteria for Kaposi Sarcoma in a resource limited setting
Citation: Infectious Agents and Cancer 2012 7(Suppl 1):P8 -
Poor immune status and systemic disease are independently associated with mortality in AIDS-related Kaposi Sarcoma in Nigeria
Citation: Infectious Agents and Cancer 2012 7(Suppl 1):P7 -
Efficacy of a latency- and productive infection-deficient Gammaherpesvirus as a vaccine strategy
Citation: Infectious Agents and Cancer 2012 7(Suppl 1):O7 -
Diagnosing Kaposi’s Sarcoma (KS) in East Africa: how accurate are clinicians and pathologists?
Citation: Infectious Agents and Cancer 2012 7(Suppl 1):P6 -
Genetic variation in KSHV encoded microRNAs affects microRNA expression and is associated with multicentric Castleman’s disease risk
Citation: Infectious Agents and Cancer 2012 7(Suppl 1):O5 -
Demographics and survival of AIDS cases with cancer, Washington, DC, 1996-2006
Citation: Infectious Agents and Cancer 2012 7(Suppl 1):P5 -
Creating a nationwide cancer registration system to support AIDS-cancer match studies in Nigeria
Citation: Infectious Agents and Cancer 2012 7(Suppl 1):P3 -
EBV-regulated global changes in mRNA isoform usage
Citation: Infectious Agents and Cancer 2012 7(Suppl 1):O3 -
The genetic landscape of immune-competent and HIV lymphoma
Citation: Infectious Agents and Cancer 2012 7(Suppl 1):O1 -
AIDS-related lymphoma at the University of calabar teaching hospital (Nigeria): a seven year review
Citation: Infectious Agents and Cancer 2012 7(Suppl 1):P1 -
Activating KIR/HLA complexes in classic Kaposi's Sarcoma
Classic Kaposi's Sarcoma (cKS) is a rare vascular tumor associated with Human Herpesvirus 8 (KSHV) infection, nevertheless not all KSHV-infected individuals have cKS.
Citation: Infectious Agents and Cancer 2012 7:9
-
Affiliated with
-
- Editorial Board
- Manuscript editing services
- Instructions for Editors
- Editors' Profile
- Sign up for article alerts and news from this journal
Follow
Annual Journal Metrics
-
Citation Impact
3.698 - 2-year Impact Factor (2021)
3.572 - 5-year Impact Factor (2021)
1.03 - Source Normalized Impact per Paper (SNIP)
0.774 - SCImago Journal Rank (SJR)Speed
24 days to first decision for all manuscripts (Median)
46 days to first decision for reviewed manuscripts only (Median)Usage
413,662 Downloads (2021)
350 Altmetric mentions (2021)
What is trending?
Click here to see which articles published in Infectious Agents and Cancer have been shared the most in the past three months.